Supplementation of a clinical trial by historical control data: is the prospect of dynamic borrowing an illusion?

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Statistics in Medicine

• Publication date

  2017-03-15

• Fields of study

  Medicine, Computer Science, Economics

• Identifiers
  DOI 10.1002/sim.7180PMID 27925274
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Supplementation of a clinical trial by historical control data: is the prospect of dynamic borrowing an illusion?

  2017cited by this paper
• Likelihood Bayesian And Mcmc Methods In Quantitative Genetics

  2016cited by this paper
• Use of historical control data for assessing treatment effects in clinical trials

  2014influential reference
• Using historical control information for the design and analysis of clinical trials with overdispersed count data

  2013cited by this paper
• The network meta-analytic-predictive approach to non-inferiority trials

  2013cited by this paper
• The inclusion of historical control data may reduce the power of a confirmatory study

  2011influential reference
• An informed reference prior for between‐study heterogeneity in meta‐analyses of binary outcomes

  2011cited by this paper
• Bayesian Statistics in Medical Devices: Innovation Sparked by the FDA

  2011cited by this paper
• Designing a non‐inferiority study in kidney transplantation: a case study

  2011cited by this paper
• Summarizing historical information on controls in clinical trials

  2010cited by this paper
• Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.

  2010cited by this paper
• A note on the power prior

  2009influential reference
• Prognostic factors in ALS: A critical review

  2009cited by this paper
• Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: A double- blind, randomized, multicentre, placebo-controlled trial

  2009cited by this paper
• Erythropoietin in amyotrophic lateral sclerosis: A pilot, randomized, double-blind, placebo-controlled study of safety and tolerability

  2009cited by this paper
• Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues

  2007influential reference
• Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.

  2007cited by this paper
• Trial of celecoxib in amyotrophic lateral sclerosis

  2006cited by this paper
• Bayesian Approaches to Clinical Trials and Health‐Care Evaluation

  2005cited by this paper
• A clinical trial of creatine in ALS

  2004cited by this paper
• How should meta‐regression analyses be undertaken and interpreted?

  2002cited by this paper
• Incorporation of historical controls using semiparametric mixed models

  2001cited by this paper
• Power prior distributions for regression models

  2000cited by this paper
• On the Use of Historical Control Data for Trend Test in Carcinogenicity Studies

  1999cited by this paper
• Bayesian Design and Analysis of Active Control Clinical Trials

  1999cited by this paper
• Using Historical Controls to Adjust for Covariates in Trend Tests for Binary Data

  1998cited by this paper
• Use of historical controls in time-adjusted trend tests for carcinogenicity.

  1996cited by this paper
• Using historical controls in the analysis of developmental toxicity data.

  1993cited by this paper
• That BLUP is a Good Thing: The Estimation of Random Effects

  1991cited by this paper
• Comment: Ethics and ECMO

  1989cited by this paper
• Incorporating Historical Controls in Testing for a Trend in Proportions

  1986cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper
• Use of Historical Control Data in Carcinogenicity Studies in Rodents

  1984cited by this paper
• Combining Historical and Randomized Controls for Assessing Trends in Proportions

  1983cited by this paper
• The use of historical control information in testing for a trend in Poisson means.

  1982influential reference
• The Use of Historical Control Information in Testing for a Trend in Proportions

  1982influential reference
• Stein's Paradox in Statistics

  1977cited by this paper
• The combination of randomized and historical controls in clinical trials.

  1976cited by this paper
• Likelihood: An account of the statistical concept of likelihood and its application to scientific inference.

  1973cited by this paper
• (www.interscience.wiley.com) DOI: 10.1002/sim.2639 Trying to be precise about vagueness

  year unknowninfluential reference

• Large Sample Inference with Dynamic Information Borrowing

  2025cites this paper
• Power priors and type I error control: constrained borrowing of external control data.

  2025cites this paper
• Methods for Combining Observational and Experimental Causal Estimates: A Review

  2025cites this paper
• Approximate Bayesian Analysis for Borrowing External Controls for Randomized Controlled Trials With Dynamic Borrowing and Covariate Balancing Adjustment

  2025cites this paper
• Using Bayesian statistics in confirmatory clinical trials in the regulatory setting: a tutorial review

  2024cites this paper
• A Bayesian Bootstrap Approach for Dynamic Borrowing for Minimizing Mean Squared Error

  2024influential citation
• Treatment effect estimation using the propensity score in clinical trials with historical control

  2024cites this paper
• Augmenting Treatment Arms With External Data Through Propensity‐Score Weighted Power Priors: An Application in Expanded Access

  2023cites this paper
• Historical controls in clinical trials: a note on linking Pocock's model with the robust mixture priors.

  2023cites this paper
• Augmenting Randomized Clinical Trial Data with Historical Control Data: Precision Medicine Applications.

  2022cites this paper
• Using information from network meta-analyses to optimize the power and sample allocation of a subsequent trial with a new treatment

  2022cites this paper
• A conservative approach to leveraging external evidence for effective clinical trial design

  2022cites this paper
• Experiment-selector cross-validated targeted maximum likelihood estimator for hybrid RCT-external data studies

  2022cites this paper
• An adaptive design for early clinical development including interim decision for single‐arm trial with external controls or randomized trial

  2022cites this paper
• Increasing the statistical power of animal experiments with historical control data

  2021cites this paper
• Diabetes management intervention studies: lessons learned from two studies

  2021cites this paper
• Implementing Historical Controls in Oncology Trials.

  2021cites this paper
• Comparison of Sample Size Requirements of Randomized and Historically Controlled Trials Based on Calibrated Error Rates

  2021cites this paper
• Incorporating Information from Completed Trials and Other Sources in Future Trial Planning

  2021cites this paper
• Platform Trial Designs

  2021cites this paper
• A historical cohort of temporal lobe surgery for medically refractory epilepsy: a systematic review and meta-analysis to guide future nonrandomized controlled trial studies.

  2020cites this paper
• Clustered allocation as a way of understanding historical controls: Components of variation and regulatory considerations

  2020influential citation
• Historical Controls in Randomized Clinical Trials: Opportunities and Challenges

  2020cites this paper
• Critical appraisal of Bayesian dynamic borrowing from an imperfectly commensurate historical control

  2020cites this paper
• A roadmap to using historical controls in clinical trials – by Drug Information Association Adaptive Design Scientific Working Group (DIA-ADSWG)

  2020cites this paper
• A Bayesian decision‐theoretic approach to incorporate preclinical information into phase I oncology trials

  2019cites this paper
• A quantitative framework to inform extrapolation decisions in children

  2019cites this paper
• Design and analysis of a clinical trial using previous trials as historical control

  2019cites this paper
• Research Pearls: How Do We Establish the Level of Evidence?

  2018cites this paper
• Approche Bayésienne de la survie dans les essais cliniques pour les cancers rares

  2018cites this paper
• Bridging the gap:using extrapolation to reduce the experimental burden in children

  2018cites this paper
• Improving the efficiency of clinical trial designs by using historical control data or adding a treatment arm to an ongoing trial

  2018cites this paper
• Historical Controls?

  2017cites this paper
• Supplementation of a clinical trial by historical control data: is the prospect of dynamic borrowing an illusion?

  2017cites this paper
• Allocating Treatments to Patients in Clinical Trials

  2008cites this paper